Open Now: The Global ETF Survey Take the Survey →

Advertisement
Advertisement
LFSC
Life Sciences
Active

F/m Emerald Life Sciences Innovation ETF

This ETF provides exposure to Other Mid and Small-Cap Equities

LFSC performance and flow charts

Last update 7/24/2026 at 7:51 PM
Live
Closed
Last price
$45.14
-$0.32 (-0.70%) 7/24/2026

Performance

0246810%Jun 24Jul 1Jul 8Jul 15Jul 22

Flows

0 M0.5 M1 M1.5 M2 M
1 day price range
$44.97
$45.47
52 week price range
$24.21
$47.39
1W perf
-1.39%
YTD perf
+23.23%
YTD flows
+$8M
AuM
$123M
E/R
0.79%
TTM yield
-
Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

Historic performance and flows

Data as of July 24, 2026
1M3MYTD1Y3Y5Y
Perf.+4.17%+20.39%+23.23%+82.30%
Flows+$2M+$3M+$8M+$17M--
Data as of July 24, 2026
Advertisement

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Characteristics

This fund is actively managed; it does not track an index. This share class generates a stream of income by distributing dividends.

Management strategyActive
StrategyLong Only
ProviderEmerald Group
N° of holdings40
Dividend policyDistributing
Trailing 12m distribution yield
Join for free
Inception dateOctober 31, 2024
ESGNo
TrackinsightTrackinsight

More data and info about LFSC on Trackinsight

Exposure

Data as of June 30, 2026

Diversification

73.24%

Total weight of top 15 holdings out of 40

Top 15 Holdings

Travere Therapeutics, Inc.
8.37%
Cogent Biosciences, Inc.
7.18%
LivaNova Plc
7.04%
Spyre Therapeutics, Inc.
6.71%
Guardant Health, Inc.
5.56%
Corcept Therapeutics, Inc.
5.27%
Mirum Pharmaceuticals, Inc.
5.25%
BillionToOne, Inc.
4.25%
Cytokinetics, Inc.
4.13%
Veradermics, Inc.
3.76%
United Therapeutics Corp.
3.55%
Trevi Therapeutics, Inc.
3.5%
Savara, Inc.
3.2%
Dianthus Therapeutics, Inc.
2.77%
Nektar Therapeutics
2.7%

Sectors

Healthcare
98.03%
Other
1.97%

Countries

USA
90.9%
United Kingdom
7.04%
Other
2.06%
Advertisement

Trading data

Last sale
7/24/2026 at 7:51 PM
$45.14
Previous close
$45.46
Consolidated volume
07/23/2026
Join for free
Average volume
30 days
Join for free
Average discount or premium
30 days
Join for free
Average Bid/Ask spread
30 days
Join for free

Volatility and drawdown

3M1Y3Y5Y
Volatility+26.23%+26.91%
Max drawdown
-6.53%-16.25%
Max drawdown duration
20d168dN/AN/A
Time to recover
8d59dN/AN/A
Advertisement
Frequently asked questions about LFSC

What type of ETF is LFSC?

LFSC is a Active ETF that provides exposure to Equity assets. It is managed by Emerald Group.

What does LFSC invest in?

This ETF provides exposure to Other Mid and Small-Cap Equities. It is part of the segment: Life Sciences.

What is the expense ratio of LFSC?

The total expense ratio (TER) of LFSC is 0.79%, representing the annual fee charged by the fund manager.

When was LFSC launched?

LFSC was launched on October 31, 2024, marking its entry into the ETF market.

Who is the issuer of LFSC?

LFSC is issued by Emerald Group.

What is the AUM of LFSC?

As of July 24, 2026, LFSC manages $123.48 M, reflecting the total assets held in the fund.

How has LFSC performed recently?

As of July 24, 2026, LFSC delivered a return of 4.17% over the past month (1M performance), 20.39% over the past three months (3M), and 23.23% year-to-date (YTD).

What are the recent fund flows for LFSC?

As of July 24, 2026, LFSC has seen net flows of +$2M in the past month (1M flow) and +$8M year-to-date (YTD).

How many holdings are in LFSC

As of June 30, 2026, LFSC holds 40 securities in its portfolio. This level of diversification can influence the fund’s risk profile and exposure to individual assets.

How diversified is LFSC?

As of June 30, 2026, LFSC holds 40 securities, with 73.24% of its assets concentrated in its top 15 holdings.

What are the top holdings of LFSC?

As of June 30, 2026, LFSC holds a portfolio of 40 underlyings, with its largest positions including Travere Therapeutics, Inc., Cogent Biosciences, Inc. and LivaNova Plc. These top holdings play a significant role in shaping the fund’s performance and exposure.

What countries or regions does LFSC invest in?

As of June 30, 2026, LFSC has its largest geographic exposures in USA and United Kingdom.

What sectors or themes does LFSC focus on?

As of June 30, 2026, LFSC is primarily exposed to Healthcare.

The ETF Institute® is now affiliated with ETF Central

The CETF certification is the only FINRA listed professional designation focused on ETFs.

ETF Institute
Advertisement
Advertisement
ETF U
Become a better investor with NYSE: The Home of ETFs
Visit the ETF U homepage
ETF Guides
Advertisement

Recent educational content

Tidal ETF Industry KPIs

ETF Trends

ETF Industry KPIs July 20, 2026

This week’s KPI data overview highlights key metrics and trends shaping the ETF landscape.

Tidal
By Tidal · July 20, 2026
Tidal ETF Industry KPIs

ETF Trends

ETF Industry KPIs July 13, 2026

This week’s KPI data overview highlights key metrics and trends shaping the ETF landscape.

Tidal
By Tidal · July 14, 2026
First Look ETF: Cash Deployment, Bond, and Hedged ETFs

First Look ETF

First Look ETF: Cash Deployment, Bond, and Hedged ETFs

In this season 6 episode of First Look ETF, Stephanie Stanton ‪examines the latest ETF marketplace trends with NYSE and guests.

ETF Guide
By ETF Guide · July 10, 2026
Tidal ETF Industry KPIs

ETF Trends

ETF Industry KPIs July 6, 2026

This week’s KPI data overview highlights key metrics and trends shaping the ETF landscape.

Tidal
By Tidal · July 7, 2026

Browse all educational columns

Advertisement
The Active Trader Report

Active Trader Report: Use of Leveraged & Inverse ETFs Way Up

Direxion partnered with Compound Insights and Vanda to explore what’s driving the evolution of active trading — and how active traders are using leveraged and inverse funds across equities, single stocks, commodities, and volatility.

Active Trader Report: Use of Leveraged & Inverse ETFs Way Up